#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14160	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2292	615.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1626	1626	C	803	C,T	754,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14160	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2292	615.5	0	HET	.	.	.	C207T,G	.	207	207	C	649	649	C	751	C,T,G	546,144,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14160	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2292	615.5	0	HET	.	.	.	C451T	.	451	451	C	893	893	C	764	C,T	345,370	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25622	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3713	688.4	0	.	n	.	0	T695C	SNP	695	695	T	1064	1064	C	745	C	700	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25622	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3713	688.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	2007	2007	G	865	G,A	810,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25622	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3713	688.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2340	2340	C	843	C	781	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25622	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3713	688.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2414	2414	A	813	A	769	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25622	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3713	688.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2966	2966	C	802	C,T	751,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1938	folP	855	855	100.0	folP.l15.c4.ctg.1	1611	119.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1031	1033	AGC	207;207;211	A;G;C	189;189;194	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5336	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3350	158.7	1	SNP	p	S91F	1	.	.	271	273	TTC	580	582	TTC	177;180;180	T;T;C	160;162;162	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5336	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3350	158.7	1	SNP	p	D95G	1	.	.	283	285	GGC	592	594	GGC	170;169;169	G;G;C	159;158;157	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5336	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3350	158.7	1	SNP	p	G95N	0	.	.	283	285	GGC	592	594	GGC	170;169;169	G;G;C	159;158;157	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1716	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1313	130.1	1	SNP	p	G45D	0	.	.	133	135	GGC	419	421	GGC	229;228;228	G;G;C	212;209;212	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	826	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	895	91.2	0	.	n	.	0	A197.	DEL	197	197	A	495	495	A	184	A	173	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6150	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2959	206.9	1	SNP	p	D86N	0	.	.	256	258	GAC	581	583	GAC	244;242;244	G;A;C	225;221;227	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6150	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2959	206.9	1	SNP	p	S87R	1	.	.	259	261	CGT	584	586	CGT	244;248;248	C;G;T	226;229;228	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6150	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2959	206.9	1	SNP	p	R87I	0	.	.	259	261	CGT	584	586	CGT	244;248;248	C;G;T	226;229;228	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6150	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2959	206.9	1	SNP	p	R87W	0	.	.	259	261	CGT	584	586	CGT	244;248;248	C;G;T	226;229;228	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6150	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2959	206.9	1	SNP	p	S88P	0	.	.	262	264	TCC	587	589	TCC	248;250;255	T;C;C	228;231;235	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4374	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2690	162.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1537	1539	GGC	201;202;204	G;G;C,T	191;193;190,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3968	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	168.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1199	1201	GCC	202;200;199	G;C;C	189;188;185	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3968	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	168.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1202	1204	ATG	198;199;201	A;T;G	188;188;190	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3968	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	168.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1214	1216	ACC	198;197;197	A;C;C	185;187;187	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3968	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	168.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1214	1216	ACC	198;197;197	A;C;C	185;187;187	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3968	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	168.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1715	1717	ACC	225;226;228	A;C,A;C,A	209;209,1;213,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3968	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	168.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1769	1771	GCG	213;212;212	G;C;G,T	194;196;194,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3968	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	168.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1769	1771	GCG	213;212;212	G;C;G,T	194;196;194,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3968	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	168.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1892	1894	GGT	179;179;178	G;G;T	166;164;165	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3968	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	168.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1901	1903	AGC	175;172;169	A;G;C	164;162;160	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3968	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2339	168.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1919	1921	CCG	163;164;160	C,G;C,G;G	130,6;132,3;126	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5930	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3229	183.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1709	1711	CCG	234;233;230	C;C;G	207;213;207	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2558	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1775	143.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	552	552	C	178	C	164	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3170	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1564	201.2	1	SNP	p	G120K	1	.	.	358	360	AAG	618	620	AAG	242;244;243	A;A;G	221;226;220	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3170	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1564	201.2	1	SNP	p	N121D	0	.	.	361	363	AAC	621	623	AAC	243;245;244	A,G;A;C	223,1;226;227	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3170	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1564	201.2	1	SNP	p	A121N	1	.	.	361	363	AAC	621	623	AAC	243;245;244	A,G;A;C	223,1;226;227	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10642	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4805	220.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1154	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1085	105.9	1	SNP	p	V57M	1	.	.	169	171	ATG	532	534	ATG	248;250;249	A;T;G	231;236;235	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
